All Articles

Birchtech launches its SEA-IX™ resin line, aiming to disrupt a consolidated market and bolster supply chains for critical nuclear and water utilities.

In a strategic move to dominate the AI infrastructure boom, AVAIO Digital has hired industry pioneer Jason Norado to execute its multi-gigawatt expansion.

Private equity firm TruArc Partners acquires Matrix Adhesives, signaling a strategic push to consolidate the booming North American adhesives market.

How a mortgage giant traded manual spreadsheets for custom AI, scaling loan volume 10x and saving millions, rewriting the playbook for growth.

IPVanish launches Threat Protection Pro, moving beyond its VPN roots to offer a unified defense against malware, trackers, and phishing with enterprise tech.

Danish firm Evaxion, backed by the Gates Foundation, uses its AI platform to design a next-gen polio vaccine, aiming to end the disease for good.

UFS, BankOnIT, and others merge into Navanta, a new powerhouse aiming to simplify technology and empower over 700 community financial institutions.

A new survey reveals a chasm between patriotic slogans and spending, as Canadian small businesses battle rising costs, cash flow crunches, and fading hope.

UBS sees dozens of its Southeast advisors on Barron's 2026 list, signaling a strategic victory in a key growth market. What does this mean for clients?

Phase 2 data for HRS/BHB-1893 show rapid efficacy and a simplified regimen, signaling a potential new era for treating hypertrophic cardiomyopathy.

Beyond apparel, Anthropologie and FARM Rio's new home line is a strategic play on maximalism, sustainability, and the power of a decade-long partnership.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.

With a fresh $6M infusion bringing its Series A to $36M, FIZE Medical is accelerating its global push for AI-powered, proactive fluid management in ICUs.

HealthEquity adds Sanford Health CEO Bill Gassen to its board, a strategic move to infuse provider-side expertise into the HSA giant's future.

A new pocket-sized, AI-powered ultrasound aims to revolutionize prenatal care in Africa, putting life-saving diagnostics into the hands of local caregivers.

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

The Christopher Street Project’s massive rally on the National Mall united thousands to demand action and directly engage lawmakers on trans rights.

A new partnership between Takara Bio and Hamilton promises to revolutionize RNA-seq, making high-throughput genomic analysis faster and more reliable.

Arax Investment Partners adds family-run Omni Financial, highlighting a major trend of boutique firms joining PE-backed giants for growth and succession.

Tenpoint Therapeutics launches YUVEZZI, a once-daily drop for presbyopia, entering a fierce market with a novel two-in-one formula for aging eyes.